AU548623B2 – Production of antibodies
– Google Patents
AU548623B2 – Production of antibodies
– Google Patents
Production of antibodies
Info
Publication number
AU548623B2
AU548623B2
AU18538/83A
AU1853883A
AU548623B2
AU 548623 B2
AU548623 B2
AU 548623B2
AU 18538/83 A
AU18538/83 A
AU 18538/83A
AU 1853883 A
AU1853883 A
AU 1853883A
AU 548623 B2
AU548623 B2
AU 548623B2
Authority
AU
Australia
Prior art keywords
antibodies
mammal
production
vaccine
hyperimmunising
Prior art date
1982-09-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU18538/83A
Other versions
AU1853883A
(en
Inventor
Margaret Anneli Linggood
Philip Porter
Jonathan Richard Powell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1982-09-02
Filing date
1983-08-30
Publication date
1985-12-19
1983-08-30
Application filed by Unilever PLC
filed
Critical
Unilever PLC
1984-03-08
Publication of AU1853883A
publication
Critical
patent/AU1853883A/en
1985-12-19
Application granted
granted
Critical
1985-12-19
Publication of AU548623B2
publication
Critical
patent/AU548623B2/en
2003-08-30
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
A23C9/00—Milk preparations; Milk powder or milk powder preparations
A23C9/20—Dietetic milk products not covered by groups A23C9/12 – A23C9/18
A—HUMAN NECESSITIES
A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
A23C11/00—Milk substitutes, e.g. coffee whitener compositions
A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
A—HUMAN NECESSITIES
A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
A23L11/60—Drinks from legumes, e.g. lupine drinks
A23L11/65—Soy drinks
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
C07K14/245—Escherichia (G)
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
Antibodies are produced by hyperimmunising a mammal, such as a cow, with a vaccine derived from E. coli bacteria. The bacterial strains in the vaccine are selected on the basis of their virulence characteristics, especially adhesion factors (pili), associated with gastroenteric disease in humans. The antibodies can be recovered from the mammal’s milk or serum, and used in human foods.
AU18538/83A
1982-09-02
1983-08-30
Production of antibodies
Ceased
AU548623B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB8225036
1982-09-02
GB8225036
1982-09-02
Publications (2)
Publication Number
Publication Date
AU1853883A
AU1853883A
(en)
1984-03-08
AU548623B2
true
AU548623B2
(en)
1985-12-19
Family
ID=10532644
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU18538/83A
Ceased
AU548623B2
(en)
1982-09-02
1983-08-30
Production of antibodies
Country Status (12)
Country
Link
EP
(1)
EP0102831B1
(en)
JP
(2)
JPS5973528A
(en)
AT
(1)
ATE43500T1
(en)
AU
(1)
AU548623B2
(en)
CA
(1)
CA1219806A
(en)
DE
(1)
DE3379937D1
(en)
DK
(1)
DK398683A
(en)
GB
(1)
GB2126236B
(en)
HK
(1)
HK91087A
(en)
IE
(1)
IE55673B1
(en)
NZ
(1)
NZ205392A
(en)
ZA
(1)
ZA836349B
(en)
Families Citing this family (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DK219084D0
(en)
*
1984-05-02
1984-05-02
Frederik Carl Peter Lindberg
ANTIGEN
JPS6399020A
(en)
*
1986-06-05
1988-04-30
ベイラ− カレツジ オブ メデイシン
Vaccine and manufacture
US4725435A
(en)
*
1986-06-18
1988-02-16
Bactex, Inc.
Vaccine composition for immunization against urinary tract infection caused by E. coli
US5106618A
(en)
*
1987-07-02
1992-04-21
Stolle Research And Development Corporation
Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
AU601510B2
(en)
*
1987-11-06
1990-09-13
Immunomed Corporation
Preparation of bacterium pili subunits and vaccines containing pili subunits
DE4026365A1
(en)
*
1990-08-21
1992-02-27
Biotest Pharma Gmbh
STERILE FILTERED COLORED MILK
ATE234855T1
(en)
*
1993-09-20
2003-04-15
Anadis Ltd
METHOD FOR PRODUCING IMMUNOGLOBULINS FROM COLOSTRUM AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
US6471966B1
(en)
1994-02-04
2002-10-29
Industrial Farmaceutica Y De Especialidades, S.A.
Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
ES2076895B1
(en)
*
1994-02-04
1996-08-16
Ind Farma Especial
FIMBRIAS-ADHESINAS OF TYPE 1 AND P ISOLATED FROM NEW STRAINS OF E. COLI, PROCEDURE FOR THEIR OBTAINING AND APPLICATIONS.
US5707678A
(en)
*
1995-04-12
1998-01-13
Galagen Inc.
Method for microfiltration of milk or colostral whey
US5670196A
(en)
*
1995-04-12
1997-09-23
Galagen Inc.
Method for microfiltration of milk or colostral whey
DE19641466A1
(en)
*
1996-10-09
1998-04-16
Biotest Pharma Gmbh
Oral use of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and a preparation therefor
US7785778B2
(en)
2002-11-25
2010-08-31
University Of Copenhagen
Porcine polymorphisms and methods for detecting them
AU2003901008A0
(en)
*
2003-03-04
2003-03-20
Anadis Ltd
Composition for the treatment and prevention of bacterial infections
Family Cites Families (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB1472624A
(en)
*
1974-09-02
1977-05-04
Canadian Patents Dev
Enteric disease vaccine
GB1560934A
(en)
*
1975-05-07
1980-02-13
Unilever Ltd
Methods for the resistance of non-human mammals to gastro-intestinal disorders
JPS5842759B2
(en)
*
1975-05-23
1983-09-21
カブシキガイシヤ バイオリサ−チセンタ−
Cellular Xenoseizouhou
GB1553664A
(en)
*
1975-06-12
1979-09-26
Unilever Ltd
Antigenic compositions
JPS52120116A
(en)
*
1976-04-02
1977-10-08
Kitasato Inst
Domestic animal colitis germ inactevated vaccine
CH627079A5
(en)
*
1977-04-15
1981-12-31
Nestle Sa
Process for preparing a protein concentrate containing immunological factors of milk origin
DE3172030D1
(en)
*
1980-09-15
1985-10-03
Bactex Inc
Immunization of humans against enterotoxogenic infection by escherichia coli
JPS5781417A
(en)
*
1980-09-15
1982-05-21
Bactex Inc
Human immunity effect imparting vaccine against escherichia coli infectious desease
JPS5784147A
(en)
*
1980-11-13
1982-05-26
Seiko Epson Corp
Manufacture of integrated circuit
1983
1983-08-26
NZ
NZ205392A
patent/NZ205392A/en
unknown
1983-08-26
ZA
ZA836349A
patent/ZA836349B/en
unknown
1983-08-30
AU
AU18538/83A
patent/AU548623B2/en
not_active
Ceased
1983-08-31
CA
CA000435803A
patent/CA1219806A/en
not_active
Expired
1983-09-01
EP
EP83305051A
patent/EP0102831B1/en
not_active
Expired
1983-09-01
JP
JP58161204A
patent/JPS5973528A/en
active
Pending
1983-09-01
DE
DE8383305051T
patent/DE3379937D1/en
not_active
Expired
1983-09-01
AT
AT83305051T
patent/ATE43500T1/en
not_active
IP Right Cessation
1983-09-01
GB
GB08323455A
patent/GB2126236B/en
not_active
Expired
1983-09-01
IE
IE2055/83A
patent/IE55673B1/en
not_active
IP Right Cessation
1983-09-01
DK
DK398683A
patent/DK398683A/en
not_active
Application Discontinuation
1987
1987-12-03
HK
HK910/87A
patent/HK91087A/en
not_active
IP Right Cessation
1989
1989-10-25
JP
JP1278336A
patent/JPH02160726A/en
active
Pending
Also Published As
Publication number
Publication date
NZ205392A
(en)
1987-03-06
DK398683D0
(en)
1983-09-01
GB8323455D0
(en)
1983-10-05
ZA836349B
(en)
1985-04-24
GB2126236B
(en)
1986-09-24
HK91087A
(en)
1987-12-11
CA1219806A
(en)
1987-03-31
IE832055L
(en)
1984-03-02
DK398683A
(en)
1984-03-03
GB2126236A
(en)
1984-03-21
EP0102831A1
(en)
1984-03-14
DE3379937D1
(en)
1989-07-06
EP0102831B1
(en)
1989-05-31
JPS5973528A
(en)
1984-04-25
AU1853883A
(en)
1984-03-08
JPH02160726A
(en)
1990-06-20
ATE43500T1
(en)
1989-06-15
IE55673B1
(en)
1990-12-19
Similar Documents
Publication
Publication Date
Title
AU548623B2
(en)
1985-12-19
Production of antibodies
EP0077734A3
(en)
1984-04-04
Production of monoclonal antibodies against bacterial adhesins
DE3163243D1
(en)
1984-05-30
Process for the production of a bacterial preparation for the prophylaxis of intestinal disturbances in poultry
GR3005768T3
(en)
1993-06-07
NZ212244A
(en)
1989-03-29
Preparation of cell surface protein of fibronectin binding properties useful as topical anti-infectant and vaccine
AU617318B2
(en)
1991-11-28
Outer membrane protein f of pseudomonas aeruginosa
FI102544B1
(en)
1998-12-31
Method for preparing an E. coli strain
NO180181B
(en)
1996-11-25
Process for the preparation of an ice-nucleating protein, plasmids and bacterial strains
DE3686158D1
(en)
1992-08-27
VACCINE AGAINST MASTITIS.
AU1887988A
(en)
1989-02-02
Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
NO900992D0
(en)
1990-03-01
PROCEDURE FOR THE PREPARATION OF A DRINK WITH A PH VALUE OF 3.6 TO 4.2 AND BASED ON ACID MILK.
AU7293387A
(en)
1987-11-19
Process for the treatment of milk for cheesemaking
DK145988A
(en)
1988-09-19
Differential pulley with blocks
EP0084522A3
(en)
1983-10-19
Plasmids and bacteria strains, and method of preparing the same
Kathiravan et al.
1987
Leptospiral antibodies in farm cattle and incontact human beings.
AU577349B2
(en)
1988-09-22
Vaccine for humans and warm-blooded animals
Lafont et al.
1980
Observations About Some Modifications of the Koch Bacillus During Ripening of Blue Cheese.
Uradzinski et al.
1985
The influence of heating on the survival of Salmonella sp. in naturally souring milk.
JPH0471465A
(en)
1992-03-06
Dental caries preventing food and its production thereof
FR2356727A1
(en)
1978-01-27
Staphylococcus aureus endo antigenic extracts – prepd. by treatment of the bacteria with glycine and polyvinyl pyrrolidone
Franzin et al.
1984
Isolation of Yersinia enterocolitica from raw milk.
Varadaraj
1983
Incidences of staphylococci in milk and milk products marketed in India.
RU94022337A
(en)
1996-01-10
PROTEUS BACTERIA STRAINS MIRABILIS – PRODUCER OF THERMAL-LABORIC ENTEROTOXIN
AU7189691A
(en)
1991-09-03
Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use
None